133 related articles for article (PubMed ID: 2866965)
1. Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
Andersson OK; Hedner T; Nyberg G
Eur J Clin Pharmacol; 1985; 29(3):281-5. PubMed ID: 2866965
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term antihypertensive effect of bopindolol once daily or once weekly.
Andersson O; Hedner T; Nyberg G
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S74-6. PubMed ID: 2439826
[TBL] [Abstract][Full Text] [Related]
3. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effect of bopindolol: a multi-centre study.
Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
[TBL] [Abstract][Full Text] [Related]
5. Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.
Widimský J; Lefflerová K; Dvorák I; Fedelesová V; Lupínek Z; Mayer O; Pinterová E
Am J Cardiol; 1991 Apr; 67(10):36B-42B. PubMed ID: 1673580
[TBL] [Abstract][Full Text] [Related]
6. Dose-finding study with bopindolol in arterial hypertension.
Willimann P; Peter R; Siegenthaler H
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the antihypertensive effects of bopindolol and metoprolol in the treatment of arterial hypertension].
Bagatin J; Kuzmanić A; Rumboldt Z; Mirić D; Naranca M; Obad M; Pivac N; Polić S; Rakić D
Med Pregl; 1990; 43(3-4):145-8. PubMed ID: 1978233
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive treatment with bopindolol alone or combined with a diuretic in general practice.
Weidmann P; Bousquet JC
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S80-7. PubMed ID: 2439828
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
[TBL] [Abstract][Full Text] [Related]
10. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
Kirch W; Axthelm T
Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
[TBL] [Abstract][Full Text] [Related]
11. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
Schiess W; Welzel D; Gugler R
Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506
[TBL] [Abstract][Full Text] [Related]
12. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
Honorato J; Galende I; Catalán M; Azanza JR
Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
[TBL] [Abstract][Full Text] [Related]
13. Effect of bopindolol on the circadian blood pressure profile in essential hypertension.
Favre L; Adamec R; Boxho G
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S60-3. PubMed ID: 2439823
[TBL] [Abstract][Full Text] [Related]
14. [Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
Welzel D; Bräutigam M
Arzneimittelforschung; 1989 Apr; 39(4):499-503. PubMed ID: 2568838
[TBL] [Abstract][Full Text] [Related]
15. Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.
van Brummelen P; Bühler FR; Amann FW; Bolli P
Eur J Clin Pharmacol; 1982; 22(6):491-3. PubMed ID: 6127218
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to age.
Hulthén UL; van Brummelen P; Amann FW; Bühler FR
J Cardiovasc Pharmacol; 1983; 5(3):426-9. PubMed ID: 6191141
[TBL] [Abstract][Full Text] [Related]
17. The antihypertensive effect of atenolol and bopindolol in the elderly.
Viskoper RJ; Laszt A; Oren S; Hochberg Y; Villa Y; Drexler I; Bregman L; Mishal J
Neth J Med; 1989 Oct; 35(3-4):185-91. PubMed ID: 2574832
[TBL] [Abstract][Full Text] [Related]
18. Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertension.
Shohat J; Modan M; Rosenfeld JB
Fundam Clin Pharmacol; 1989; 3(1):53-8. PubMed ID: 2565862
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
[TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive effect of bopindolol on stroke-prone spontaneously hypertensive rats (SHRSP)].
Yamashita K; Shigematsu K; Maeda T; Ishida Y; Niwa M; Ozaki M
Nihon Yakurigaku Zasshi; 1989 Jan; 93(1):7-15. PubMed ID: 2565861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
